In a study by Ramiro et al. [23], the integration of biomarkers such as endostatin, IL-6 and TNF-R1 with clinical variables achieved an AUC of approximately 0.75 for predicting long-term mortality (5 years) after ischemic stroke. This evidence concerns the gene IL6 and ischemic stroke.